Angioplasty for the treatment of acute myocardial infarction 10 Simes JR, Weaver DW, Ellis SG, Grines CL. Overview of the randomised trials of primary PTCA and thrombolysis in acute myocardial infarction [abstract]. Circulation 1997;94(suppl) However, recent multicentre data from the GUSTO IIb trial5 suggest that the overall differences between primary angioplasty and accelerated tissue plasminogen activator (t-PA) are rather small, and point to the need for subgroup analysis. High risk patients, and probably patients with a contraindication to thrombolysis, are emerging as those with the best indications for primary angioplasty. After a rather unequal competition between both strategies during the first 10 years of the reperfusion era, an unpleasant and unjustified feeling of revenge has been perceptible behind several affirmations favouring primary angioplasty. We should stop competing and concentrate on the real issues. These include making primary angioplasty available for the subset of patients most likely to benefit from the procedure, and organising adequate referral networks. It must then be the responsibility of every physician to make the best decision after a thorough (but swift) evaluation of the individual patient's situation. 
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